AtriCure Future Growth
Future criteria checks 1/6
AtriCure is forecast to grow earnings and revenue by 5.9% and 12.8% per annum respectively. EPS is expected to grow by 8.6% per annum. Return on equity is forecast to be -3.2% in 3 years.
Key information
5.9%
Earnings growth rate
8.6%
EPS growth rate
Medical Equipment earnings growth | 16.5% |
Revenue growth rate | 12.8% |
Future return on equity | -3.2% |
Analyst coverage | Good |
Last updated | 20 Mar 2024 |
Recent future growth updates
Recent updates
Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump
Apr 04Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?
Mar 14Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues
Jan 21Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Nov 29AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price
Sep 27Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?
Aug 02AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion
Jun 15Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Apr 14Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)
Mar 02What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?
Feb 09Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Dec 28Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?
Sep 06An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued
Aug 02AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks
Jun 13Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Jun 08Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?
May 08Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Is AtriCure (NASDAQ:ATRC) A Risky Investment?
Feb 18Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching
Jan 20Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)
Nov 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 595 | -20 | 41 | 60 | 6 |
12/31/2025 | 526 | -27 | 17 | 33 | 9 |
12/31/2024 | 461 | -34 | N/A | 14 | 9 |
12/31/2023 | 399 | -30 | -8 | 4 | N/A |
9/30/2023 | 381 | -25 | -13 | 1 | N/A |
6/30/2023 | 366 | -28 | -48 | -3 | N/A |
3/31/2023 | 349 | -38 | -18 | -2 | N/A |
12/31/2022 | 330 | -46 | -39 | -22 | N/A |
9/30/2022 | 316 | -56 | -37 | -22 | N/A |
6/30/2022 | 303 | 53 | -32 | -20 | N/A |
3/31/2022 | 290 | 52 | -41 | -29 | N/A |
12/31/2021 | 274 | 50 | -24 | -14 | N/A |
9/30/2021 | 259 | 45 | -18 | -10 | N/A |
6/30/2021 | 243 | -57 | -14 | -6 | N/A |
3/31/2021 | 213 | -49 | -18 | -13 | N/A |
12/31/2020 | 207 | -48 | -25 | -20 | N/A |
9/30/2020 | 210 | -46 | -36 | -27 | N/A |
6/30/2020 | 212 | -50 | -44 | -34 | N/A |
3/31/2020 | 230 | -46 | -31 | -18 | N/A |
12/31/2019 | 231 | -35 | -28 | -16 | N/A |
9/30/2019 | 222 | -23 | -20 | -11 | N/A |
6/30/2019 | 216 | -20 | -11 | -3 | N/A |
3/31/2019 | 209 | -17 | -14 | -8 | N/A |
12/31/2018 | 202 | -21 | -10 | -4 | N/A |
9/30/2018 | 195 | -20 | -10 | -4 | N/A |
6/30/2018 | 187 | -20 | -15 | -9 | N/A |
3/31/2018 | 180 | -27 | -16 | -9 | N/A |
12/31/2017 | 175 | -27 | -15 | -9 | N/A |
9/30/2017 | 170 | -33 | N/A | -10 | N/A |
6/30/2017 | 166 | -32 | N/A | -9 | N/A |
3/31/2017 | 160 | -34 | N/A | -14 | N/A |
12/31/2016 | 155 | -33 | N/A | -15 | N/A |
9/30/2016 | 150 | -36 | N/A | -20 | N/A |
6/30/2016 | 143 | -35 | N/A | -18 | N/A |
3/31/2016 | 135 | -32 | N/A | -10 | N/A |
12/31/2015 | 129 | -27 | N/A | -8 | N/A |
9/30/2015 | 123 | -22 | N/A | -6 | N/A |
6/30/2015 | 118 | -16 | N/A | -10 | N/A |
3/31/2015 | 112 | -14 | N/A | -16 | N/A |
12/31/2014 | 107 | -16 | N/A | -22 | N/A |
9/30/2014 | 99 | -16 | N/A | -23 | N/A |
6/30/2014 | 93 | -18 | N/A | -21 | N/A |
3/31/2014 | 87 | -17 | N/A | -17 | N/A |
12/31/2013 | 81 | -11 | N/A | -5 | N/A |
9/30/2013 | 78 | -9 | N/A | -2 | N/A |
6/30/2013 | 74 | -8 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ATRC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ATRC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ATRC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ATRC's revenue (12.8% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: ATRC's revenue (12.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ATRC is forecast to be unprofitable in 3 years.